AL Amyloidosis Clinical Trials in Nashville, Tennessee
2 recruitingNashville, Tennessee
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
AmyloidosisLight Chain AmyloidosisRelapsed AL Amyloidosis+1 more
Alexion Pharmaceuticals, Inc.91 enrolled18 locationsNCT07081646
Recruiting
Phase 1Phase 2
Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
AmyloidosisAL Amyloidosis
University of Texas Southwestern Medical Center37 enrolled3 locationsNCT05145816